Christie acquires Luminetx

Christie, a visual technologies company, has acquired all the assets of Luminetx, a medical biosciences technology company.

The assets include Luminetx’ technology and intellectual property for the vascular imaging system, VienViewer. Christie will create a new medical products business operating under Christie Medical Holdings.

“Christie’s goal is to diversify into emerging markets and we saw...[an] opportunity to enter the medical imaging industry,” said George Pinho, president of Christie Medical.

Michael Bassett,

Contributor

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.